Exact Mass: 420.2220032

Exact Mass Matches: 420.2220032

Found 33 metabolites which its exact mass value is equals to given mass value 420.2220032, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Levocabastine

(3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid

C26H29FN2O2 (420.22129459999996)


Levocabastine is only found in individuals that have used or taken this drug. It is a selective second-generation H1-receptor antagonist used for allergic conjunctivitis. Levocabastine was discovered at Janssen Pharmaceutica in 1979.Levocabastine is a potent, selective histamine H1-receptor antagonist. It works by competing with histamine for H1-receptor sites on effector cells. It thereby prevents, but does not reverse, responses mediated by histamine alone. Levocabastine does not block histamine release but, rather, prevents histamine binding and activity. Levocabastine also binds neurotensin 2 receptors and serves as a neurotensin agonist. This can induce some degree of analgesia. R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

Cabastine

1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid

C26H29FN2O2 (420.22129459999996)


D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists

   

8-(3-(1-((3-Fluorophenyl)methyl)-4-piperidinyl)-1-oxopropyl)-1,2,5,6-tetrahydro-4h-pyrrolo(3,2,1-ij)quinolin-4-one

6-(3-{1-[(4-fluorophenyl)methyl]piperidin-4-yl}propanoyl)-1-azatricyclo[6.3.1.0^{4,12}]dodeca-4,6,8(12)-trien-11-one

C26H29FN2O2 (420.22129459999996)


   

8-[3-[1-[(3-Fluorophenyl)methyl]-4-piperidinyl]-1-oxopropyl]-1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-ij]quinoline-4-one

6-(3-{1-[(3-fluorophenyl)methyl]piperidin-4-yl}propanoyl)-1-azatricyclo[6.3.1.0^{4,12}]dodeca-4,6,8(12)-trien-11-one

C26H29FN2O2 (420.22129459999996)


   

Ile Ser Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C17H32N4O8 (420.2220032)


   

Ile Thr Ser Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C17H32N4O8 (420.2220032)


   

Ile Thr Thr Ser

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C17H32N4O8 (420.2220032)


   

Leu Ser Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C17H32N4O8 (420.2220032)


   

Leu Thr Ser Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C17H32N4O8 (420.2220032)


   

Leu Thr Thr Ser

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C17H32N4O8 (420.2220032)


   

Ser Ile Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C17H32N4O8 (420.2220032)


   

Ser Leu Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C17H32N4O8 (420.2220032)


   

Ser Thr Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

C17H32N4O8 (420.2220032)


   

Ser Thr Leu Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

C17H32N4O8 (420.2220032)


   

Ser Thr Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

C17H32N4O8 (420.2220032)


   

Ser Thr Thr Leu

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

C17H32N4O8 (420.2220032)


   

Thr Ile Ser Thr

(2S,3R)-2-[(2S)-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C17H32N4O8 (420.2220032)


   

Thr Ile Thr Ser

(2S)-2-[(2S,3R)-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C17H32N4O8 (420.2220032)


   

Thr Leu Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C17H32N4O8 (420.2220032)


   

Thr Leu Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C17H32N4O8 (420.2220032)


   

Thr Ser Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

C17H32N4O8 (420.2220032)


   

Thr Ser Leu Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

C17H32N4O8 (420.2220032)


   

Thr Ser Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

C17H32N4O8 (420.2220032)


   

Thr Ser Thr Leu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

C17H32N4O8 (420.2220032)


   

Thr Thr Ile Ser

(2S)-2-[(2S,3S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C17H32N4O8 (420.2220032)


   

Thr Thr Leu Ser

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C17H32N4O8 (420.2220032)


   

Thr Thr Ser Ile

(2S,3S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C17H32N4O8 (420.2220032)


   

Thr Thr Ser Leu

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C17H32N4O8 (420.2220032)


   

Thr Thr Thr Val

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C17H32N4O8 (420.2220032)


   

Thr Thr Val Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C17H32N4O8 (420.2220032)


   

Thr Val Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C17H32N4O8 (420.2220032)


   

Val Thr Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C17H32N4O8 (420.2220032)


   

Cabastine

(3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid

C26H29FN2O2 (420.22129459999996)


R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist